1[1]Pollack M H,Marzol P C. Panic:course,complication and treatment of panic disorder[J]. J Psychopharmacol,2000,14(2Suppl 1):S25-30.
2[2]Birchall H,Brandon S,Taub N. Panic in a general practice population:prevalence,psychiatric comorbidity and associated disability[J].Soc Psychiatry Psychiatr Epidemiol,2000,35(6):235-341.
3[3]Pollack M H,Rapaport M H,Clary C M,et al. Sertraline treatment of panic disorder:response in patients at risk for poor outcome[J].J Clin Psychiatry,2000,61(12):922-977.
5[5]Fava M,Rankin M A,Wright E C,et al. Anxiety disorders in major depression[J]. Compr Psychiatry,2000,41(2):97-102.
6[6]Pollack MH,Worthington JJ 3rd,Otto MW,et al.Venlafaxine for panic disorder:results from a double-blind,placebo-controlled study.Psychopharmacol Bull,1996,32:667
7[7]Ribeiro L,Busnellu JV,Kauer-Sant'Anna M,et al.Mirtazapine versus fuoxetine in the treatment of panic disorder.Braz J Med Biol Res,2001,34:1303
8[8]Sheehan DV,Raj AB,Harnett-Sheehan K,et al.The relative efficacy of high-dose buspirone and alprazolam in the treatment of panic disorder:a double-blind placebo-controlled stydy.Acta Psychiatr Scand,1993,88:1
9[9]Mavissakalian M,Perel JM.Clinical experiments in maintenance and discontinuation of imipramine therapy in panic disorder with agoraphobia.Arch Gen Psychiatry,1992,49:318
10[10]Curtis GC,Massana J,Udina C,et al.Maintenance drug therapy of panic disorder.J Psychiatr Res,1993,27(suppl 1):127
